GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bachem Holding AG (XSWX:BANB) » Definitions » Total Liabilities

Bachem Holding AG (XSWX:BANB) Total Liabilities : CHF362.4 Mil (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Bachem Holding AG Total Liabilities?

Bachem Holding AG's Total Liabilities for the quarter that ended in Dec. 2023 was CHF362.4 Mil.

Bachem Holding AG's quarterly Total Liabilities increased from Dec. 2022 (CHF214.21 Mil) to Jun. 2023 (CHF250.76 Mil) and increased from Jun. 2023 (CHF250.76 Mil) to Dec. 2023 (CHF362.36 Mil).

Bachem Holding AG's annual Total Liabilities increased from Dec. 2021 (CHF177.50 Mil) to Dec. 2022 (CHF214.21 Mil) and increased from Dec. 2022 (CHF214.21 Mil) to Dec. 2023 (CHF362.36 Mil).


Bachem Holding AG Total Liabilities Historical Data

The historical data trend for Bachem Holding AG's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bachem Holding AG Total Liabilities Chart

Bachem Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 199.33 235.17 177.50 214.21 362.36

Bachem Holding AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 177.50 149.19 214.21 250.76 362.36

Bachem Holding AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Bachem Holding AG's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=164.72+(0.218+197.419
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=362.4

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=1682.88-1320.523
=362.4

Bachem Holding AG's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=164.72+(0.218+197.419
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=362.4

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=1682.88-1320.523
=362.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bachem Holding AG Total Liabilities Related Terms

Thank you for viewing the detailed overview of Bachem Holding AG's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Bachem Holding AG (XSWX:BANB) Business Description

Traded in Other Exchanges
Address
Hauptstrasse 144, Bubendorf, CHE, 4416
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients, as well as on the development of biochemical products for research purposes. The group markets its product under the Bachem and Clinalfa brands. The business of the firm can be seen booming across the market of Switzerland, USA, Austria, Great Britain, Germany and internationally and it generates revenue through the sale of the product.

Bachem Holding AG (XSWX:BANB) Headlines

No Headlines